Trial NCT04651790
Publication Bueno S, medRxiv, 2021
Primary outcome on the report: The primary aim was to evaluate the frequency of solicited and unsolicited AEs that occur during 7 days after each dose, stratified by age group (aged 18-59 and ≥60).

Note: The risk of bias by domain corresponds to the highest risk of bias among outcomes by domain.
The overall risk of bias corresponds to the overall highest risk of bias assessed among outcomes.